CBSE Grade 12 Biology: Biotechnology and its Applications

40 min read

On this page

This chapter covers the principles, tools, and applications of biotechnology, explaining how biological systems are manipulated to create medical, agricultural, and environmental solutions. Readers will understand core techniques like PCR, genetic engineering, and gene therapy, and how these innovations address global challenges in healthcare, food security, and sustainability.

What is Biotechnology and Why is it Important?

What is Biotechnology?

Biotechnology is the integrated use of biochemistry, microbiology, genetic engineering, and process technology to develop products and services using living organisms or their components. It operates at the cellular or molecular level to modify biological systems.

The term was coined in 1919 by Karl Ereky, a Hungarian engineer. Modern biotechnology relies on DNA manipulation, such as recombinant DNA technology, to alter the genetic makeup of organisms for specific purposes.

Why is Biotechnology Significant in Biology?

Biotechnology bridges the gap between biology and technology, enabling scientists to engineer living systems for practical applications. Its significance lies in its ability to address critical challenges in health, agriculture, and the environment.

(i) It allows precise modification of genetic material, unlike traditional breeding methods that rely on random mutations. (ii) It accelerates the development of therapeutic proteins, vaccines, and diagnostic tools. (iii) It enhances crop yield, nutritional value, and resistance to pests without relying on chemical pesticides.

Key Applications of Biotechnology

Biotechnology has transformed multiple fields by providing innovative solutions:

Medicine: Production of human insulin using Escherichia coli bacteria (1982), gene therapy for treating genetic disorders like severe combined immunodeficiency (SCID), and monoclonal antibodies for cancer treatment.
Agriculture: Development of Bt crops (e.g., Bt cotton) that produce their own insecticide, reducing the need for external pesticide applications by 40-60%.
Environmental Conservation: Use of bioremediation to clean oil spills, such as the 2010 Deepwater Horizon spill, where Alcanivorax borkumensis bacteria degraded hydrocarbons.
Industrial Processes: Fermentation technology for producing biofuels like ethanol from sugarcane, reducing greenhouse gas emissions by 50-90% compared to fossil fuels.

How Does Biotechnology Differ from Traditional Biology?

Traditional biology observes and describes natural processes, while biotechnology actively manipulates them for human benefit. For example:

Table. Columns: Basis · Traditional Biology · Biotechnology
Approach — Traditional Biology: Observational and descriptive · Biotechnology: Interventional and applied
Tools Used — Traditional Biology: Microscopes, stains, dissection · Biotechnology: PCR, CRISPR-Cas9, gel electrophoresis
Timeframe — Traditional Biology: Generations (e.g., selective breeding) · Biotechnology: Days to weeks (e.g., gene cloning)
Precision — Traditional Biology: Low (random mutations) · Biotechnology: High (targeted genetic edits)
Example — Traditional Biology: Cross-breeding wheat for disease resistance · Biotechnology: Inserting Cry1Ac gene into cotton for pest resistance

Why Does Biotechnology Matter for the Future?

Biotechnology is a cornerstone of modern science because it offers solutions to global challenges. It enables the production of personalized medicines, such as CAR-T cell therapy for leukemia, and the development of climate-resilient crops to combat food insecurity.

Moreover, it addresses ethical and environmental concerns by promoting sustainable practices, such as the use of biofertilizers to reduce chemical runoff. As biotechnology advances, it will continue to redefine the boundaries of medicine, agriculture, and environmental conservation.

Note: Do not confuse biotechnology with traditional biochemistry. Biotechnology involves the practical application of biological systems to create products, while biochemistry focuses on the chemical processes within living organisms.

How Do Biotechnology Tools Work?

How do PCR and DNA sequencing work as biotechnology tools?

Biotechnology relies on precise DNA manipulation tools such as PCR (Polymerase Chain Reaction) and DNA sequencing to read, copy, and analyse genetic material. These tools enable scientists to amplify tiny DNA samples for study or to decode entire genomes. PCR mimics natural DNA replication in a test tube, while DNA sequencing reads the order of nucleotides like a molecular barcode. Together, they form the backbone of modern genetic analysis, diagnostics, and research.

What are the steps of PCR and what does each stage do?

PCR is an in vitro method to make millions of copies of a specific DNA segment in hours. It uses three repeating steps in a thermal cycler: denaturation, annealing, and extension. In denaturation (94–98 °C), the double helix separates into single strands. Next, annealing (50–65 °C) allows short primers to bind to complementary sequences on each template strand. Finally, extension (72 °C) uses Taq DNA polymerase—isolated from Thermus aquaticus bacteria—to add nucleotides, synthesising new DNA strands. Each cycle doubles the target DNA, producing exponential amplification.

Diagram: PCR components and workflow. Labelled parts: A. Thermal cycler block, B. Reaction mix tube (DNA template, primers, dNTPs, Taq polymerase, buffer), C. Denaturation stage (95 °C), D. Annealing stage (55 °C), E. Extension stage (72 °C), F. Amplified DNA product. Notice how the DNA quantity doubles every cycle.

How does DNA sequencing read the genetic code?

DNA sequencing determines the exact order of A, T, C, and G nucleotides in a DNA molecule. The Sanger method, developed by Frederick Sanger in 1977, remains exam-favourite for its chain-termination principle. It uses four separate reactions, each with a small amount of a dideoxynucleotide (ddNTP) that stops DNA synthesis at a specific base. When separated by gel electrophoresis, DNA fragments form a ladder revealing the nucleotide sequence. Modern next-generation methods automate this process, enabling whole-genome sequencing in days.

Diagram: Sanger sequencing workflow. Labelled parts: A. Single-stranded DNA template, B. Primer, C. DNA polymerase, D. dNTPs, E. ddNTPs (A*, T*, C*, G*), F. Gel electrophoresis lanes showing fragment separation by size, G. Laser detector reading fluorescent labels. Notice how shorter fragments migrate faster and indicate earlier termination points.

Why is gel electrophoresis essential after PCR or sequencing?

Gel electrophoresis separates DNA fragments by size under an electric field. A agarose or polyacrylamide gel acts as a molecular sieve; smaller fragments move faster toward the positive electrode. After staining with ethidium bromide, bands become visible under UV light. This technique validates PCR success by confirming product length, checks sequencing reactions for purity, and even diagnoses genetic disorders by detecting abnormal fragment patterns. Without it, amplified DNA or sequence data would remain invisible and unusable.

What are the exam-favourite applications of these tools?

At CBSE Grade 12, expect questions linking these tools to gene therapy, recombinant vaccines, and forensic DNA profiling. For example, PCR amplifies viral DNA from patient samples for COVID-19 RT-PCR tests, while sequencing identifies mutations in the BRCA1 gene linked to breast cancer. Gel electrophoresis separates DNA fragments in DNA fingerprinting to match suspects or identify human remains. Mastering these steps ensures high scores in application-based questions.

Note: Do not confuse PCR with DNA sequencing. PCR makes copies; sequencing reads order. One tool amplifies, the other decodes.

How do these tools demonstrate precision, scalability, and sustainability?

PCR delivers precision by targeting specific sequences with primers, avoiding off-target amplification. It scales from microlitre reactions to high-throughput 384-well plates for population screening. Sequencing scales similarly, shifting from capillary electrophoresis to massively parallel platforms that sequence a human genome in under 24 hours. Sustainability arises from reduced reagent volumes and energy-efficient thermal cyclers, cutting both costs and carbon footprint compared to older cloning methods.

What is Genetic Engineering and How is it Used?

Genetic engineering is the direct manipulation of an organism's DNA to introduce desired traits. This process involves the use of recombinant DNA technology to create genetically modified organisms.

The genetic engineering process can be broken down into several steps: (i) isolation of the target gene, (ii) selection of a vector, and (iii) transfer of the gene into a host cell.

The target gene is isolated from an organism using various techniques such as PCR or DNA sequencing.
A vector is selected to carry the target gene into the host cell. Common vectors include plasmids or viruses.
The target gene is then inserted into the vector using restriction enzymes and ligases.
The vector is then introduced into the host cell using various methods such as transformation or transfection.

The applications of genetic engineering are vast and include the production of human insulin, monoclonal antibodies, and genetically modified crops such as Bt crops.

Derivation: Genetic Engineering Process

Isolation of the target gene: The target gene is isolated from an organism using various techniques such as PCR or DNA sequencing.
Selection of a vector: A vector is selected to carry the target gene into the host cell. Common vectors include plasmids or viruses.
Transfer of the gene into a host cell: The vector is then introduced into the host cell using various methods such as transformation or transfection.

Result: The genetic engineering process results in the creation of genetically modified organisms with desired traits.

Diagram: Genetic Engineering Process. The diagram shows the steps involved in the genetic engineering process, including the isolation of the target gene, selection of a vector, and transfer of the gene into a host cell. The labelled parts include: A) Target gene, B) Vector, C) Host cell, D) Restriction enzymes, E) Ligases, F) Transformed host cell.

Features of Genetic Engineering

Genetic engineering has several features that make it a powerful tool for biotechnology applications. These include: (i) precision, (ii) efficiency, and (iii) versatility.

Table: Comparison of Genetic Engineering and Traditional Breeding. Columns: Basis · Genetic Engineering · Traditional Breeding
Method — Genetic Engineering: Direct manipulation of DNA · Traditional Breeding: Selection of desired traits
Precision — Genetic Engineering: High · Traditional Breeding: Low
Efficiency — Genetic Engineering: High · Traditional Breeding: Low
Versatility — Genetic Engineering: High · Traditional Breeding: Low

How Does Gene Therapy Work?

What is Gene Therapy?

Gene therapy is a medical treatment that uses gene editing to correct defective genes in human patients.

It involves CRISPR-Cas9, a tool used to edit genes and treat diseases like cystic fibrosis.

How Does Gene Therapy Work?

Identification of the defective gene: The gene responsible for the disease is identified.
Isolation of the normal gene: A normal copy of the gene is isolated from a healthy individual.
Delivery of the normal gene: The normal gene is delivered to the patient's cells using a vector, such as a virus.
Expression of the normal gene: The normal gene is expressed in the patient's cells, producing a healthy protein.

Gene therapy has the potential to treat a wide range of genetic diseases, including sickle cell anemia and muscular dystrophy.

Diagram: Gene Therapy Process. Draw a flowchart showing the steps involved in gene therapy, including identification of the defective gene, isolation of the normal gene, delivery of the normal gene, and expression of the normal gene. Label the parts A-D, where A is the identification of the defective gene, B is the isolation of the normal gene, C is the delivery of the normal gene, and D is the expression of the normal gene.

Types of Gene Therapy

There are two main types of gene therapy: germline gene therapy and somatic gene therapy.

Germline gene therapy involves editing the genes in reproductive cells, such as eggs or sperm, to prevent the passing of genetic diseases to future generations.

Somatic gene therapy involves editing the genes in non-reproductive cells, such as skin or blood cells, to treat genetic diseases in an individual.

Diagram: Types of Gene Therapy. Draw a diagram showing the difference between germline gene therapy and somatic gene therapy. Label the parts A-B, where A is germline gene therapy and B is somatic gene therapy.

What are the Applications of Biotechnology in Agriculture: Bt Crops?

Biotechnology has revolutionized agriculture by introducing genetically modified crops, such as Bt cotton and golden rice. These crops have improved yields, increased resistance to pests, and enhanced nutritional content.

In India, Bt cotton has been widely adopted, resulting in a 40-60% increase in crop yields. This has not only improved the livelihoods of farmers but also contributed to the country's food security.

The development of genetically modified crops involves the use of recombinant DNA technology, which allows scientists to manipulate genes and introduce desirable traits into crops. This technology has the potential to address global food security challenges and improve the nutritional content of crops.

Why are Bt Crops Important?

Bt crops are important because they provide resistance to pests, reducing the need for pesticides and minimizing the environmental impact of agriculture. Additionally, Bt crops can improve food security by increasing crop yields and reducing crop losses.

In India, the use of Bt cotton has been shown to reduce pesticide use by 50-90%, resulting in significant environmental and health benefits. Furthermore, Bt crops can help address the challenges of climate change by providing crops that are more resilient to extreme weather conditions.

Diagram: Bt Crop Development. Draw a diagram showing the steps involved in developing Bt crops, including the isolation of genes, the use of vectors, and the introduction of genes into crops. Label the parts A-F, where A is the isolation of genes, B is the use of vectors, C is the introduction of genes into crops, D is the cultivation of Bt crops, E is the monitoring of crop yields, and F is the evaluation of environmental impact.

How are Bt Crops Developed?

The development of Bt crops involves several steps, including the isolation of genes, the use of vectors, and the introduction of genes into crops. This process requires a deep understanding of genetic engineering and the use of biotechnology tools, such as PCR and DNA sequencing.

In addition to Bt crops, biotechnology has also been used to develop nutritionally enhanced crops, such as golden rice, which is enriched with vitamin A. These crops have the potential to address micronutrient deficiencies and improve the health and well-being of people around the world.

What are the Applications of Biotechnology in Agriculture: Nutritionally Enhanced Crops?

Biotechnology has been used to develop nutritionally enhanced crops with improved nutritional content. For example, Golden Rice is a type of rice that has been genetically engineered to produce beta-carotene, a precursor to vitamin A.

In India, the Indian Council of Agricultural Research has developed nutritionally enhanced crops such as iron-rich wheat and zinc-rich rice. These crops have the potential to improve the nutritional status of millions of people in India.

Why are Nutritionally Enhanced Crops Important?

Nutritionally enhanced crops are important because they can help to address micronutrient deficiencies in developing countries. For example, vitamin A deficiency is a major public health problem in many developing countries, and Golden Rice has the potential to help address this problem.

The development of nutritionally enhanced crops involves several steps, including genetic engineering, field trials, and regulatory approvals. In India, the Genetic Engineering Approval Committee is responsible for regulating the development and release of genetically modified crops.

How are Nutritionally Enhanced Crops Developed?

Identification of the gene to be introduced into the crop plant
Genetic engineering of the crop plant using recombinant DNA technology
Field trials to test the safety and efficacy of the genetically modified crop
Regulatory approvals from government agencies such as the Genetic Engineering Approval Committee

The development of nutritionally enhanced crops has the potential to improve the nutritional status of millions of people in India and other developing countries. However, it also raises ethical concerns such as the potential for unintended consequences on human health and the environment.

Diagram: Nutritionally Enhanced Crops. A diagram showing the different steps involved in the development of nutritionally enhanced crops, including genetic engineering, field trials, and regulatory approvals. Labelled parts include the crop plant, the gene to be introduced, and the regulatory agencies involved.

What are the Applications of Biotechnology in Medicine: Therapeutic Applications?

What are the therapeutic applications of biotechnology in medicine?

Biotechnology enables precision medicine by engineering biological molecules for targeted therapy. Insulin, the first recombinant therapeutic protein, transformed diabetes care after its 1982 FDA approval. Produced by Escherichia coli carrying the human insulin gene, it replaced porcine insulin, reducing immune reactions and ensuring scalability for global supply.

How does gene therapy restore defective genes?

Gene therapy delivers functional genes to replace or silence defective ones. In 2017, the FDA approved Luxturna for inherited retinal disease caused by mutations in the RPE65 gene. Administered via adeno-associated virus vectors, it restores vision by introducing a functional copy of RPE65 into retinal cells, demonstrating the personalization of therapeutic interventions.

Why are genetically engineered proteins used in treating diseases?

Recombinant DNA technology produces therapeutic proteins like tissue plasminogen activator (tPA) for stroke treatment and human growth hormone for pituitary dwarfism. These proteins are synthesized in host cells (e.g., E. coli or mammalian cells) after inserting the target gene, ensuring high purity and consistency. Their production leverages bioreactors with capacities up to 20,000 liters, meeting clinical demand.

What are the challenges in therapeutic biotechnology?

Delivery systems must overcome immunogenicity and off-target effects. Viral vectors, while efficient, can trigger immune responses, as seen in early trials for ornithine transcarbamylase deficiency. Non-viral vectors (e.g., lipid nanoparticles) offer safer alternatives but often face lower transfection efficiency. Balancing scalability with safety remains a critical hurdle for widespread adoption.

How do monoclonal antibodies revolutionize cancer therapy?

Monoclonal antibodies like rituximab (targeting CD20 on B-cells) and trastuzumab (targeting HER2 in breast cancer) bind specific antigens to inhibit tumor growth. Produced via hybridoma technology (developed by Georges Köhler and César Milstein, 1975), these antibodies are engineered for high specificity, reducing collateral damage to healthy cells compared to chemotherapy.

What role does biotechnology play in enzyme replacement therapy?

Enzyme deficiencies, such as in Gaucher disease, are treated by administering recombinant enzymes (e.g., imiglucerase). These enzymes are produced in mammalian cell cultures to ensure proper glycosylation, which is critical for in vivo stability and function. The therapy, administered biweekly, alleviates symptoms by compensating for the missing enzymatic activity.

What are the Applications of Biotechnology in Medicine: Vaccines and Diagnostics?

Biotechnology has revolutionized the field of medicine by providing innovative solutions for the prevention and diagnosis of diseases. One of the key applications of biotechnology in medicine is the development of recombinant vaccines. These vaccines are produced using genetic engineering techniques, where the genetic material of a virus or bacteria is inserted into a vector, such as a plasmid, to produce a recombinant protein.

The use of biotechnology in medicine has also led to the development of diagnostic tools, such as PCR (Polymerase Chain Reaction) and DNA sequencing. These tools enable the rapid and accurate diagnosis of diseases, allowing for early intervention and treatment. For example, COVID-19 RT-PCR tests have been widely used to diagnose the disease.

How are Vaccines Developed using Biotechnology?

The development of vaccines using biotechnology involves several steps, including isolation of the target gene, selection of a vector, and transfer of the gene into a host cell. The host cell then produces the recombinant protein, which is used as the vaccine. This approach has been used to develop vaccines against diseases such as hepatitis B and human papillomavirus (HPV).

Named people such as Jonas Salk and Albert Sabin have made significant contributions to the development of vaccines using biotechnology. Their work has led to the development of inactivated vaccines and live attenuated vaccines, which have been used to control and prevent the spread of diseases.

What are the Benefits of Biotechnology in Medicine?

The use of biotechnology in medicine has several benefits, including precision, scalability, and sustainability. Biotechnology-based diagnostic tools and vaccines can be produced on a large scale, making them more accessible and affordable. Additionally, biotechnology has enabled the development of personalized medicine, where treatments are tailored to an individual's specific needs.

Applications of biotechnology in medicine include the development of gene therapy, which involves the use of genes to treat diseases. Gene therapy has been used to treat diseases such as severe combined immunodeficiency (SCID) and leukemia. Biotechnology has also been used to develop recombinant enzymes, which are used to treat diseases such as Gaucher disease.

How Does Biotechnology Contribute to Environmental Conservation: Pollution Control?

What is the role of biotechnology in environmental conservation?

Biotechnology contributes to environmental conservation through various applications, including bioremediation and biodegradation. These processes involve the use of microorganisms to clean up pollutants in the environment.

For example, bioremediation can be used to clean up oil spills by using microorganisms that can break down the oil. This approach is more environmentally friendly than traditional methods, which can harm the environment.

Another application of biotechnology in environmental conservation is the production of biofuels. Biofuels are fuels that are made from living organisms, such as plants and microorganisms. They are a renewable energy source and can help reduce our reliance on fossil fuels.

How does biotechnology contribute to pollution control?

Biotechnology can contribute to pollution control by providing alternative methods for cleaning up pollutants. For example, bioremediation can be used to clean up contaminated soil and groundwater.

The applications of biotechnology in environmental conservation are numerous. Some of the key applications include:

Bioremediation: the use of microorganisms to clean up pollutants in the environment
Biodegradation: the use of microorganisms to break down pollutants in the environment
Biofuels: the production of fuels from living organisms, such as plants and microorganisms

When considering the use of biotechnology for environmental conservation, several decision factors must be taken into account, including the effectiveness of the technology, the cost of implementation, and the potential environmental impacts.

The why of biotechnology in environmental conservation is clear: it provides a sustainable and environmentally friendly approach to cleaning up pollutants and reducing our reliance on fossil fuels.

How Does Biotechnology Contribute to Environmental Conservation: Sustainable Energy?

Why does biotechnology matter for sustainable energy?

Biotechnology uses living cells and enzymes to convert renewable biomass into energy, cutting fossil-fuel use and lowering greenhouse-gas emissions. Biofuels such as ethanol and biodiesel are produced by microbial fermentation or enzymatic digestion of plant sugars and oils, replacing gasoline and diesel without new engine designs. Algal biorefineries grow in wastewater, using sunlight and CO₂ to generate lipids that are then transesterified into biodiesel, simultaneously cleaning water and capturing carbon. Methanogenic bacteria in anaerobic digesters convert agricultural residues into biogas (60 % CH₄, 40 % CO₂) that can be upgraded to pipeline-quality methane or used on-site for heat and power, achieving an energy return on investment of 3–5 : 1.

What decision factors decide which biotechnology route to choose?

Three decisionFactors dominate selection: Precision of feedstock conversion, Scalability of the process, and Sustainability of the whole value chain.

Precision is governed by enzyme specificity or microbial strain engineering. For example, Saccharomyces cerevisiae strains engineered with amylolytic pathways directly ferment starch to ethanol at 90 % theoretical yield, eliminating separate saccharification steps and reducing capital cost by 15 %. Scalability depends on feedstock logistics and reactor design; corn-stover-to-ethanol plants in Iowa (USA) operate at 200 ML y⁻¹ using continuous enzymatic hydrolysis at 50 °C, while microalgal systems scale in modular 100 m³ photobioreactors to avoid light limitation. Sustainability is judged by life-cycle assessment (LCA) metrics: GHG savings ≥ 50 % relative to fossil diesel, water footprint ≤ 50 L L⁻¹ biodiesel, and net energy ratio ≥ 2.

How is biotechnology applied in practice today?

Two applicationsWhy categories dominate current deployment.

Liquid biofuels
1. First-generation ethanol from sugarcane (Brazil) and corn (USA) supplies 40 % of transport fuel in Brazil, cutting CO₂ by 90 % versus gasoline when electricity from bagasse is credited.
2. Second-generation ethanol from lignocellulosic residues (corn stover, wheat straw) uses engineered Trichoderma cellulases at 50 °C to hydrolyse cellulose to glucose, followed by Zymomonas mobilis fermentation, reaching titres of 40 g L⁻¹ in 48 h.
3. Biodiesel from Jatropha oil or algal lipids is produced by lipase-catalysed transesterification at 40 °C, yielding FAME (fatty-acid methyl esters) that meet EN 14214 cold-flow and oxidation-stability specs.
Biogas and power
1. Danish centralized biogas plants co-digest manure, straw and food waste in 3 000 m³ CSTRs at 37 °C, producing 12 MW electricity plus 18 MJ heat per tonne feedstock.
2. Household digesters in India (Deenbandhu model) convert 2 kg cattle dung d⁻¹ into 1 m³ biogas (≈ 21 MJ), replacing 4 kg firewood and cutting indoor PM₂.₅ by 80 %.

What limits wider adoption?

Economic barriers include feedstock price volatility and capital cost of enzyme production (≈ 20 % of ethanol cost). Policy barriers include inconsistent subsidies and blending mandates; the EU Renewable Energy Directive II mandates 14 % renewable energy in transport by 2030 but caps crop-based biofuels at 1 %. Technological barriers include lignin recalcitrance in second-generation routes and low lipid productivity in outdoor algal ponds (< 20 t ha⁻¹ y⁻¹). Overcoming these requires integrated biorefineries that co-produce fuels, chemicals and power, and CRISPR-engineered microbial consortia that achieve consolidated bioprocessing.

Diagram: Integrated biorefinery for sustainable energy. Labelled parts: (A) Feedstock handling, (B) Pretreatment reactor, (C) Enzymatic hydrolysis tank, (D) Fermentation vessel with engineered microbes, (E) Product recovery distillation column, (F) Anaerobic digester for waste valorisation. Notice the closed-loop water system and on-site CHP unit.

What are the Ethical Issues in Biotechnology?

Biotechnology has raised several ethical concerns, including patenting life forms, which involves granting ownership rights to companies over living organisms. This has sparked debates about the morality of treating life as a commodity.

Another issue is genetic privacy, as advances in DNA manipulation and sequencing have made it possible to access and manipulate individual genetic information. This raises concerns about the potential for genetic discrimination and the need for strict regulations to protect genetic privacy.

The ethics of biotechnology are complex and multifaceted, involving considerations of merits such as improved crop yields and disease resistance, as well as limitations such as the potential for unintended consequences and unequal access to benefits.

How are Ethical Issues in Biotechnology Addressed?

The act citation of the Biotechnology Regulatory Authority of India (BRAI) Act, 2013, provides a framework for regulating biotechnology in India. However, the implementation of such regulations is often challenging due to the rapid pace of technological advancements.

A comparison table of different countries' approaches to biotechnology regulation highlights the varying levels of stringency and oversight.

Table: Biotechnology Regulation Comparison. Columns: Basis · India · USA · EU
Regulatory Framework — India: BRAI Act, 2013 · USA: Coordinated Framework for Regulation of Biotechnology · EU: Directive 2001/18/EC
Scope of Regulation — India: Biotechnology products and processes · USA: Biotechnology products and processes · EU: Deliberate release of GMOs
Level of Stringency — India: Moderate · USA: Variable · EU: High
Public Participation — India: Limited · USA: Encouraged · EU: Mandatory

The ethical issues in biotechnology are far-reaching and require careful consideration of the merits and limitations of this technology. As biotechnology continues to evolve, it is essential to address these concerns through effective regulation, public engagement, and ongoing evaluation.

What are the Experiments and Techniques Used in Biotechnology?

What experiments prove DNA is the genetic material?

In 1928, Frederick Griffith’s pneumococcus experiments showed a “transforming principle” that changed harmless R-strain bacteria into lethal S-strain. Oswald Avery, Colin MacLeod and Maclyn McCarty (1944) purified this principle and proved it was DNA by enzymatically destroying proteins, RNA and polysaccharides—transformation still occurred only when DNase was omitted. This established DNA as the molecule of heredity.

How is a gene isolated for cloning?

The target gene is first amplified from genomic DNA using PCR. A typical 30-cycle programme runs: (i) 95 °C for 30 s to denature, (ii) 55 °C for 30 s to anneal primers, (iii) 72 °C for 1 min per kb for extension by Taq DNA polymerase. Primers are 18–25 nt oligos matching flanking sequences; Mg²⁺ and dNTPs supply raw material. Result: micrograms of pure gene ready for ligation.

Worked example 1. Amplify a 500 bp gene from 1 ng template with 30 cycles.

Given: 1 ng template = 1×10⁻¹² g; 1 bp ≈ 660 g mol⁻¹; Avogadro’s number 6×10²³ mol⁻¹.
Formula: copies = (template mass / bp mass) × 6×10²³ × 2^cycles
Substitute: bp mass = 500 × 660 / 6×10²³ g ≈ 5.5×10⁻¹⁹ g
copies = (1×10⁻¹² / 5.5×10⁻¹⁹) × 6×10²³ × 2³⁰ ≈ 1.1×10¹² copies
Answer: 1.1×10¹² copies

How do we insert a gene into a host cell?

Two common routes exist. Plasmid vectors (e.g., pBR322) carry an ori for bacterial replication, an amp^r marker and a multiple cloning site. Foreign DNA is ligated at restriction sites (EcoRI, BamHI) with T4 DNA ligase at 16 °C overnight. Agrobacterium tumefaciens Ti plasmid is used for plants: the T-DNA region is replaced by the gene of interest and transferred to plant cells via infection.

Note: Plasmid vectors replicate independently; Ti plasmid integrates into plant genome.

How do we confirm the gene entered the host?

Two checks are routine. First, antibiotic selection: transformed cells survive on ampicillin plates while untransformed cells die. Second, blue-white screening: vectors carrying the insert disrupt the lacZ’ gene; colonies remain white on X-gal media, blue colonies lack the insert.

What is the role of gel electrophoresis?

Gel electrophoresis separates DNA fragments by size. An agarose gel (0.8–2 %) is submerged in TAE buffer; 5–10 µL of loading dye is mixed with sample. At 80–120 V for 45–60 min, smaller fragments migrate faster. The gel is stained with ethidium bromide and viewed under UV; band intensity correlates with DNA quantity.

Diagram: Gel electrophoresis workflow. A: Gel tray with comb, B: Casting tray with gel, C: Electrophoresis chamber with buffer, D: Power supply, E: UV transilluminator, F: Gel with DNA bands. Notice the 1 kb DNA ladder lane on the left for size reference.

How is gene expression verified after cloning?

Two assays are used. Colony PCR amplifies the insert directly from bacterial colonies using vector-specific primers; a band of expected size confirms presence. qRT-PCR measures mRNA levels: total RNA is reverse transcribed to cDNA, then amplified with gene-specific primers; fluorescence (SYBR Green) quantifies transcript abundance.

Why compare Sanger vs Next-Generation Sequencing?

Sanger sequencing (1977) uses dideoxynucleotides to terminate chains; fragments are resolved on polyacrylamide gels and read manually. NGS platforms (Illumina 2006) parallelise millions of reads by fragmenting DNA, ligating adapters, and imaging fluorescent nucleotides during synthesis. While Sanger reads ~900 bp per reaction at 99.9 % accuracy, NGS yields gigabases per run at 98 % accuracy but requires higher computational assembly.

Table: Comparison of DNA sequencing methods. Columns: Basis · Sanger (Chain-Termination) · Illumina (NGS) · Oxford Nanopore
Read length — Sanger (Chain-Termination): 400–900 bp · Illumina (NGS): 50–300 bp · Oxford Nanopore: 10 kb–2 Mb
Accuracy — Sanger (Chain-Termination): 99.9 % · Illumina (NGS): 98–99 % · Oxford Nanopore: 92–97 %
Throughput — Sanger (Chain-Termination): ~100 kb/run · Illumina (NGS): ~30 Gb/run · Oxford Nanopore: ~50 Gb/run
Cost per Mb — Sanger (Chain-Termination): ~US$0.50 · Illumina (NGS): ~US$0.01 · Oxford Nanopore: ~US$0.05
Key enzyme — Sanger (Chain-Termination): Taq DNA polymerase · Illumina (NGS): DNA polymerase + reversible terminators · Oxford Nanopore: Motor protein

What ethical safeguards govern these experiments?

In India, the Rules 1989 under the Environment (Protection) Act mandate Institutional Biosafety Committees for rDNA work. Containment levels range from ML-I (basic lab) to ML-IV (high-risk pathogens). Public participation is encouraged through RTI disclosures and public hearings before deliberate release of GMOs, balancing innovation with precaution.

How Do Biotechnology Techniques Involve Numerical Calculations?

Biotechnology techniques, such as PCR and DNA sequencing, involve numerical calculations to analyze and manipulate DNA sequences. These calculations are essential to understand the genetic code and make informed decisions in biotechnology applications.

One of the key numerical calculations in biotechnology is the estimation of the number of possible combinations of DNA sequences. For example, in PCR, the number of possible combinations of primers and probes can be calculated using the formula:

Number of combinations = 2^n

where n is the number of primers or probes

For instance, if there are 5 primers, the number of possible combinations would be 2^5 = 32.

Worked Example 1:

Worked example 2. A researcher wants to amplify a specific DNA sequence using PCR. The sequence is 1000 base pairs long, and the researcher wants to use 10 primers. Calculate the number of possible combinations of primers.

Given: sequence length = 1000 bp, number of primers = 10

Formula: number of combinations = 2^n

Substitute: n = 10

Answer: number of combinations = 2^10 = 1024

value unit: combinations

Derivation:

Step 1: Understand the problem and identify the relevant formula.
Step 2: Substitute the given values into the formula.
Step 3: Calculate the result using the formula.
Step 4: Interpret the result in the context of the problem.

result and its consequence: The number of possible combinations of primers is 1024, which means that there are 1024 different ways to amplify the specific DNA sequence using 10 primers.

Glossary

annealing — In PCR, the step where primers bind to the single-stranded DNA template at a lower temperature, typically 50–65 °C, enabling DNA polymerase to extend the strand.
bioremediation — Use of microorganisms to break down environmental pollutants, such as using Alcanivorax borkumensis to degrade oil after the Deepwater Horizon spill.
biotechnology — Integrated use of biochemistry, microbiology, genetic engineering, and process technology to develop products or services using living organisms or their components.
CRISPR-Cas9 — A gene-editing tool that uses a guide RNA and Cas9 enzyme to precisely cut and modify DNA sequences, enabling targeted genetic corrections.
denaturation — In PCR, the high-temperature step (94–98 °C) that separates double-stranded DNA into single strands for replication.
DNA sequencing — Technique to determine the exact order of nucleotides (A, T, C, G) in a DNA molecule, essential for identifying mutations and studying genomes.
gel electrophoresis — Laboratory method that separates DNA fragments by size using an electric field and a gel matrix, visualized after staining with ethidium bromide.
gene therapy — Medical treatment that introduces, replaces, or edits genes in a patient's cells to correct defective genes causing diseases like SCID or cystic fibrosis.
genetic engineering — Direct manipulation of an organism's DNA using recombinant DNA technology to introduce desired traits, creating genetically modified organisms (GMOs).
monoclonal antibodies — Laboratory-produced antibodies derived from a single B-cell clone, used in therapies like cancer treatment and diagnostics due to their specificity.
PCR (Polymerase Chain Reaction) — In vitro technique to rapidly amplify millions of copies of a specific DNA segment using primers, Taq polymerase, and repeated thermal cycling.
recombinant DNA technology — Process of combining DNA from different sources to create genetically modified organisms or produce therapeutic proteins like human insulin.
restriction enzymes — Bacterial enzymes that cut DNA at specific recognition sequences, used in genetic engineering to isolate and manipulate target genes.
Sanger sequencing — Chain-termination method of DNA sequencing developed by Frederick Sanger, historically exam-favourite for its accuracy in reading nucleotide order.
somatic gene therapy — Gene therapy that targets non-reproductive cells (e.g., skin or blood cells) to treat genetic disorders in an individual without altering the germline.
vaccine (recombinant) — Vaccine produced using biotechnology by inserting a pathogen gene into a host (e.g., yeast or bacteria) to generate antigens for immune response, such as hepatitis B vaccine.
vector — A carrier, such as a plasmid or virus, used to transfer foreign DNA into a host cell during genetic engineering or gene therapy.

Common errors and misconceptions

Misconception: Biotechnology is the same as traditional biochemistry. Correct: Biotechnology applies biological systems to create practical products, while biochemistry studies chemical processes within living organisms. Distinguishing these ensures correct application in exam questions about scope and tools.
Misconception: PCR and DNA sequencing are interchangeable tools. Correct: PCR amplifies DNA copies; sequencing reads the nucleotide order. One makes copies, the other decodes them. Knowing their distinct roles is critical for interpreting lab techniques in exam scenarios.
Misconception: Gene therapy always alters the patient’s germline cells. Correct: Most gene therapy targets somatic cells; germline therapy edits reproductive cells and is ethically restricted. Understanding this distinction is key for ethical and application-based questions.
Misconception: Bt crops produce their own pesticides continuously, harming all insects. Correct: Bt crops produce the Bt toxin only in specific tissues and target certain pests; they reduce pesticide use by 40–60% without harming all insects. Corrects misconceptions about ecological impact and efficacy in agriculture questions.
Misconception: Golden Rice was developed to increase crop yield. Correct: Golden Rice was engineered to produce beta-carotene (provitamin A) to address vitamin A deficiency, not to boost yield. Focuses on nutritional enhancement rather than productivity in application-based questions.
Misconception: Ethical concerns in biotechnology are limited to environmental risks. Correct: Ethical issues include genetic privacy, patenting life forms, and unequal access to benefits, alongside environmental and health risks. Broadens understanding of ethical dimensions in biotechnology for exam discussions.
Misconception: All genetically modified crops require external pesticide application. Correct: Bt crops produce their own insecticide (Bt toxin), reducing the need for external pesticides by up to 90% in some cases. Clarifies the role of GM crops in sustainable agriculture for exam answers.
Misconception: Insulin produced by biotechnology is identical to pig or cow insulin. Correct: Recombinant human insulin, produced using E. coli, is structurally identical to human insulin, unlike animal derived insulin. Ensures accuracy in therapeutic applications and historical context questions.
Misconception: Gene therapy can cure all genetic diseases immediately. Correct: Gene therapy is promising but faces challenges like delivery efficiency, immune responses, and long-term safety, limiting immediate widespread use. Highlights limitations for therapeutic application questions.
Misconception: PCR can only be used for DNA amplification, not diagnostics. Correct: PCR is widely used in diagnostics, such as RT-PCR for COVID-19, to detect and amplify pathogen-specific DNA or RNA from patient samples. Emphasizes the diagnostic utility of PCR in medical applications.

Exam-style questions with model answers

Q1. State the year in which the term 'biotechnology' was coined and name the scientist who introduced it. Explain its significance in modern biology in 30–50 words. [2 marks]

Answer:

Term coined in 1919 by Karl Ereky, a Hungarian engineer.
Significance: Modern biotechnology manipulates DNA, enabling gene editing, therapeutic protein production, and disease-resistant crops, bridging theory and real-world applications.

Q2. List any two key differences between traditional biology and biotechnology. How does biotechnology demonstrate scalability in industrial production? (30–50 words) [2 marks]

Answer:

Traditional biology observes natural processes; biotechnology actively manipulates them to create novel outcomes.
Biotechnology scales laboratory discoveries (e.g., insulin synthesis) to industrial production, ensuring mass availability.

Q3. Describe the three stages of PCR (Polymerase Chain Reaction) and explain the role of Taq polymerase in this process. Support your answer with the temperature ranges involved. (60–100 words) [3 marks]

Answer:

Denaturation: DNA template is heated to 94–98 °C to separate double strands into single strands.
Annealing: Temperature is lowered to 50–65 °C to allow primers to bind to complementary sequences.
Extension: Taq polymerase synthesizes new DNA strands at 72 °C, using free nucleotides.
Role of Taq polymerase: A heat-stable enzyme that extends primers to synthesize new DNA strands during the extension phase.

Q4. Explain the principle of gel electrophoresis and its importance in DNA analysis. How does the size of DNA fragments affect their migration in the gel? (80–120 words) [4 marks]

Answer:

Principle: Gel electrophoresis separates DNA fragments by size under an electric field. Agarose or polyacrylamide gel acts as a molecular sieve.
Importance: Used after PCR or sequencing to visualize and analyze DNA fragments, confirming amplification or identifying mutations.
Migration: Smaller fragments move faster toward the positive electrode due to less resistance, while larger fragments migrate slower. Bands become visible after staining with ethidium bromide.

Q5. A researcher performs a PCR to amplify a 500 bp DNA segment. The reaction mixture includes 2 µL of DNA template, 1 µL each of forward and reverse primers, 10 µL of master mix, and 6 µL of water. Calculate the total volume of the reaction mixture. If the researcher wants to run 10 such reactions, what is the total volume of the master mix required? Show your calculations. (60–100 words) [3 marks]

Answer:

Total volume per reaction: 2 µL (template) + 1 µL (forward primer) + 1 µL (reverse primer) + 10 µL (master mix) + 6 µL (water) = 20 µL.
Total master mix for 10 reactions: 10 µL/reaction × 10 reactions = 100 µL.

Q6. Compare and contrast the Sanger sequencing method with Next-Generation Sequencing (NGS). Highlight their applications in genetic disorder diagnosis and personalized medicine. (110–180 words) [5 marks]

Answer:

Sanger Sequencing: Developed by Frederick Sanger in 1977, uses chain-termination principle with four separate reactions. It is precise but low-throughput, ideal for sequencing single genes or small regions (e.g., BRCA1 gene for breast cancer risk assessment).
Next-Generation Sequencing (NGS): High-throughput, parallel sequencing of millions of fragments. Enables whole-genome sequencing, detecting mutations across multiple genes (e.g., identifying genetic disorders like sickle cell anemia or cystic fibrosis).
Applications: Sanger is cost-effective for targeted sequencing; NGS is preferred for comprehensive genetic profiling in personalized medicine, enabling tailored treatments based on individual genetic makeup.

Q7. Outline the step-by-step process of genetic engineering used to produce recombinant human insulin. Include the role of vectors and host cells in your answer. (110–180 words) [5 marks]

Answer:

Isolation of Target Gene: The human insulin gene is isolated from genomic DNA using restriction enzymes (e.g., EcoRI), which cut DNA at specific sequences to produce sticky ends.
Selection of Vector: A plasmid vector (e.g., pBR322) is chosen, containing an origin of replication, selectable markers (e.g., amp^(r)), and a multiple cloning site (MCS).
Insertion of Gene into Vector: The insulin gene is inserted into the vector using DNA ligase, forming recombinant DNA.
Transfer into Host Cell: The recombinant plasmid is introduced into Escherichia coli via transformation (e.g., using calcium chloride or electroporation).
Selection and Screening: Host cells are grown on selective media (e.g., ampicillin agar) to identify transformants. PCR or blue-white screening confirms the presence of the insulin gene.
Expression of Gene: The host cell transcribes and translates the insulin gene, producing recombinant human insulin (e.g., Humulin).

Q8. Case-Based Question:
In 2023, a farmer in Maharashtra reported a 30% increase in cotton yield after switching to Bt cotton. However, environmentalists raised concerns about the long-term impact of Bt crops on soil health and biodiversity.

(a) What is Bt cotton, and how does it achieve pest resistance?
(b) Explain the mechanism of action of the Bt toxin in controlling bollworms.
(c) Discuss the ethical and environmental concerns associated with Bt crops. (110–180 words) [5 marks]

Answer:

Bt Cotton: Genetically modified cotton engineered to produce Bacillus thuringiensis (Bt) toxin, which kills specific pests like bollworms.
Mechanism of Bt Toxin: The Bt toxin binds to receptors in the gut of bollworms, creating pores in the gut lining. This disrupts digestion, leading to larval death within 2–3 days.
Ethical/Environmental Concerns:
- Soil Health: Overuse of Bt crops may reduce microbial diversity in soil.
- Biodiversity: Non-target insects (e.g., butterflies) may be affected.
- Pest Resistance: Bollworms may develop resistance to Bt toxin over time.
- Regulation: Need for strict monitoring to balance agricultural benefits with ecological safety.

Q9. Explain the process of gene therapy for treating a genetic disorder like sickle cell anemia. Include the types of gene therapy, delivery vectors, and challenges involved. (160–220 words) [6 marks]

Answer:

Gene Therapy Process:
- Identification: The defective HBB gene causing sickle cell anemia is identified.
- Isolation: A normal copy of the HBB gene is isolated from a healthy individual.
- Delivery: The normal gene is delivered to patient’s cells using a viral vector (e.g., adeno-associated virus or lentivirus).
- Expression: The normal gene is expressed, producing healthy hemoglobin.
Types of Gene Therapy:
- Somatic Gene Therapy: Targets non-reproductive cells (e.g., bone marrow cells) to treat the patient.
- Germline Gene Therapy: Edits reproductive cells (e.g., sperm or eggs) to prevent passing the disorder to future generations (ethically controversial).
Challenges:
- Delivery Efficiency: Ensuring the gene reaches target cells without off-target effects.
- Immune Response: Viral vectors may trigger immune reactions.
- Long-Term Safety: Risks of unintended mutations or cancer.
- Ethical Concerns: Germline editing raises questions about human germline modification.

Q10. Assertion-Reason Question:
Assertion (A): Biotechnology tools like PCR and DNA sequencing are essential for diagnosing genetic disorders.
Reason (R): PCR amplifies DNA for analysis, while DNA sequencing reads the genetic code to identify mutations.

Evaluate the assertion and reason and choose the correct option:
(i) Both A and R are true, and R is the correct explanation of A.
(ii) Both A and R are true, but R is not the correct explanation of A.
(iii) A is true, but R is false.
(iv) A is false, but R is true. (20–50 words) [1 marks]

Answer: (i) Both A and R are true, and R is the correct explanation of A.

Explanation: PCR amplifies DNA for analysis, while DNA sequencing reads the genetic code to identify mutations, making both tools essential for diagnosing genetic disorders.

Key takeaways

Biotechnology integrates biochemistry, microbiology, and genetic engineering to develop products using living organisms or their components, operating at cellular or molecular levels.
PCR (Polymerase Chain Reaction) amplifies specific DNA segments in hours using three steps: denaturation (94–98 °C), annealing, and extension, enabling rapid DNA copying for analysis or diagnostics.
DNA sequencing, pioneered by Frederick Sanger in 1977, decodes the exact order of nucleotides (A, T, C, G) in a DNA molecule using chain-termination chemistry.
Genetic engineering involves isolating a target gene (e.g., human insulin gene) using restriction enzymes, inserting it into a vector (e.g., plasmid pBR322), and transferring it into a host cell (e.g., *Escherichia coli*) for protein production.
Gene therapy corrects defective genes in patients using tools like CRISPR-Cas9, with applications in treating diseases such as cystic fibrosis and sickle cell anemia through somatic or germline approaches.
Bt crops, like Bt cotton in India, are genetically modified to produce toxins that kill pests (e.g., bollworms), reducing pesticide use and increasing crop yields while addressing food security.
Recombinant vaccines (e.g., hepatitis B vaccine) and diagnostic tools (e.g., PCR for COVID-19 detection) are produced using biotechnology, enabling precise and scalable medical solutions.
Biotechnology contributes to environmental conservation through bioremediation (e.g., oil-spill cleanup using bacteria) and biofuel production (e.g., ethanol from sugarcane), reducing reliance on fossil fuels.
Ethical concerns in biotechnology include patenting life forms, genetic privacy, and regulatory challenges, with frameworks like India’s BRAI Act (2013) addressing oversight and equitable access.

Test yourself

What is the definition of biotechnology as described in the chapter?

Biotechnology is the integrated use of biochemistry, microbiology, genetic engineering, and process technology to develop products and services using living organisms or their components.

Who coined the term 'biotechnology' and in what year?

The term biotechnology was coined in 1919 by Karl Ereky, a Hungarian engineer.

What are the three repeating steps of PCR, and what happens during each step?

PCR uses denaturation (94–98 °C to separate DNA strands), annealing (primers bind to single strands), and extension (Taq polymerase synthesizes new DNA strands).

What is the purpose of gel electrophoresis in biotechnology?

Gel electrophoresis separates DNA fragments by size under an electric field, allowing visualization of bands after staining with ethidium bromide.

What is the role of restriction enzymes in genetic engineering?

Restriction enzymes cut DNA at specific sequences, producing sticky or blunt ends to isolate a target gene (e.g., human insulin gene) for insertion into a vector.

Name two types of gene therapy and describe their key difference.

Germline gene therapy edits reproductive cells to prevent genetic diseases in future generations, while somatic gene therapy edits non-reproductive cells to treat diseases in an individual.

What is the significance of Golden Rice in biotechnology?

Golden Rice is a nutritionally enhanced crop genetically engineered to produce beta-carotene, addressing vitamin A deficiency in developing countries.

How does bioremediation contribute to environmental conservation?

Bioremediation uses microorganisms to degrade pollutants, such as cleaning up oil spills by breaking down oil into less harmful substances.

What are the four components required for a PCR reaction mix?

A PCR reaction mix includes a DNA template, primers, deoxyribonucleotide triphosphates (dNTPs), and Taq polymerase in a buffer solution.

What is the primary difference between traditional biology and biotechnology?

Traditional biology focuses on observing and describing natural processes, while biotechnology actively manipulates these processes to create novel outcomes (e.g., gene editing or recombinant protein production).

More on Class 12 - Biology Notes → Explore World 101 →